NASDAQ:SYRA Syra Health (SYRA) Stock Price, News & Analysis $0.11 -0.01 (-5.58%) As of 05/28/2025 03:28 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Syra Health Stock (NASDAQ:SYRA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Syra Health alerts:Sign Up Key Stats Today's Range$0.10▼$0.1250-Day Range$0.05▼$0.3352-Week Range$0.03▼$1.73Volume38,448 shsAverage Volume753,491 shsMarket Capitalization$1.28 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSyra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.Read More… Syra Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks16th Percentile Overall ScoreSYRA MarketRank™: Syra Health scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Syra Health. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Syra Health is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Syra Health is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSyra Health has a P/B Ratio of 0.18. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Syra Health's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.75% of the float of Syra Health has been sold short.Short Interest Ratio / Days to CoverSyra Health has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Syra Health has recently decreased by 57.58%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSyra Health does not currently pay a dividend.Dividend GrowthSyra Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.75% of the float of Syra Health has been sold short.Short Interest Ratio / Days to CoverSyra Health has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Syra Health has recently decreased by 57.58%, indicating that investor sentiment is improving significantly. News and Social Media1.0 / 5News Sentiment-0.25 News SentimentSyra Health has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Syra Health this week, compared to 4 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Syra Health insiders have not sold or bought any company stock.Percentage Held by Insiders10.18% of the stock of Syra Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 4.75% of the stock of Syra Health is held by institutions.Read more about Syra Health's insider trading history. Receive SYRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syra Health and its competitors with MarketBeat's FREE daily newsletter. Email Address SYRA Stock News HeadlinesIn Syria, Aid Cuts Threaten to Feed the Return of ISISMay 28 at 12:12 AM | msn.comSyra Health Selected for $5.8 Million Indiana Child Mental Health ProgramMay 27 at 8:55 AM | prnewswire.comIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.May 29, 2025 | Colonial Metals (Ad)Al-Jalajel discusses challenges in Syria's health sector with Syrian counterpartMay 22, 2025 | msn.comSyra Health Board Begins CEO Search to Drive GrowthMay 20, 2025 | prnewswire.comTrump announces plan to lift punishing sanctions on SyriaMay 14, 2025 | msn.comSyra Health Corp. (SYRA) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comEarnings call transcript: Syra Health sees stock surge despite net loss in Q1 2025May 9, 2025 | investing.comSee More Headlines SYRA Stock Analysis - Frequently Asked Questions How have SYRA shares performed this year? Syra Health's stock was trading at $0.4119 at the beginning of 2025. Since then, SYRA shares have decreased by 72.5% and is now trading at $0.1133. View the best growth stocks for 2025 here. How were Syra Health's earnings last quarter? Syra Health Corp. (NASDAQ:SYRA) released its quarterly earnings data on Tuesday, March, 11th. The company reported ($0.05) earnings per share (EPS) for the quarter. The company had revenue of $2 million for the quarter, compared to analyst estimates of $2.01 million. Syra Health had a negative trailing twelve-month return on equity of 131.94% and a negative net margin of 54.90%. Read the conference call transcript. When did Syra Health IPO? Syra Health (SYRA) raised $7 million in an IPO on Friday, September 29th 2023. The company issued 1,600,000 shares at a price of $4.13 per share. Kingswood acted as the underwriter for the IPO. How do I buy shares of Syra Health? Shares of SYRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Syra Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Syra Health investors own include American Airlines Group (AAL), Meta Platforms (META), PACCAR (PCAR), Super Micro Computer (SMCI), Arista Networks (ANET), Darden Restaurants (DRI) and Fabrinet (FN). Company Calendar Last Earnings3/11/2025Today5/29/2025Next Earnings (Estimated)8/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Employment agencies Sub-IndustryBusiness Services Current SymbolNASDAQ:SYRA Previous SymbolNASDAQ:SYRA CIK1922335 Webwww.syrahealth.com Phone463-345-8950FaxN/AEmployees78Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.94 million Net Margins-54.90% Pretax Margin-54.90% Return on Equity-131.94% Return on Assets-99.19% Debt Debt-to-Equity RatioN/A Current Ratio4.63 Quick Ratio4.63 Sales & Book Value Annual Sales$7.98 million Price / Sales0.16 Cash FlowN/A Price / Cash FlowN/A Book Value$0.62 per share Price / Book0.18Miscellaneous Outstanding Shares11,339,000Free Float10,156,000Market Cap$1.28 million OptionableNot Optionable Beta3.98 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NASDAQ:SYRA) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syra Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syra Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.